Detalhe da pesquisa
1.
TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes.
Ann Oncol
; 35(4): 392-401, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-38244927
2.
Modified irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC): a single-institution experience.
Med Oncol
; 33(4): 37, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26995224